Replimune Group, Inc (REPL) Stock Price

15.60 ▼ -0.28 (-1.76%)
Open: 15.76 Vol: 1.67M Day's range: 15.56 - 16.15 Aug 27, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
REPL Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL NEUTRAL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 15.64▼ 15.76▼ 15.84▼ 15.35▲ 13.72▲
MA10 15.68▼ 15.87▼ 15.82▼ 15.08▲ 12.27▲
MA20 15.75▼ 15.82▼ 15.70▼ 14.02▲ 9.06▲
MA50 15.89▼ 15.50▲ 15.13▲ 11.70▲ 8.23▲
MA100 15.85▼ 15.14▲ 14.86▲ 8.40▲ 9.23▲
MA200 15.72▼ 14.66▲ 12.51▲ 8.40▲ 12.10▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.012▼ -0.051▼ -0.036▼ 0.065▲ 0.729▲
RSI 30.479▼ 45.620▼ 51.935▲ 63.667▲ 70.549▲
STOCH 15.493▼ 27.282     50.709     72.440     84.755▲
WILL %R -85.484▼ -92.174▼ -48.848     -14.175▲ -4.709▲
CCI -101.949▼ -156.783▼ -38.281     116.044▲ 154.777▲
Latest Filters Detected On REPL
MA $REPL Price Crossed Above MA(7) Set Alert
▲ BREAK $REPL Price Breaks 60 Days High Set Alert
▲ BREAK $REPL Price Breaks 30 Days High Set Alert
▲ BREAK $REPL Price Breaks 20 Days High Set Alert
▲ BREAK $REPL Price Breaks 10 Days High Set Alert
CDL $REPL Marubozu Candlestick Pattern Detected Set Alert
Replimune Group, Inc News
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday, August 19, 2026 09:01 AM
WOBURN, Mass., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...
Did You Lose Money Investing in Replimune Group, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About their Rights Against REPL
Monday, August 17, 2026 02:01 PM
Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.
Why Is Replimune (NASDAQ:REPL) Drawing Attention After Its Oncology Approval?
Friday, August 14, 2026 12:58 PM
Strong regulatory momentum lifted attention across the biotech sector. Replimune moved into focus after its oncolytic immunotherapy earned accelerated regulatory approval, marking a milestone for the ...
REPL historical stock data
date open high low close volume
27/08/26 15.76 16.15 15.56 15.60 1,670,644
26/08/26 15.60 15.99 15.045 15.88 2,372,787
25/08/26 14.63 15.89 14.60 15.80 3,133,551
24/08/26 14.63 15.02 14.10 14.705 2,029,723
21/08/26 13.86 14.98 13.81 14.77 2,944,017
20/08/26 14.55 14.75 13.92 14.05 4,270,508
19/08/26 15.17 15.64 14.73 14.81 3,374,613
18/08/26 14.50 15.615 14.50 15.58 2,223,858
17/08/26 14.65 14.69 14.05 14.63 3,679,874
14/08/26 15.19 15.39 14.69 14.97 2,346,670
Quote Details
52wk Low:1.50
52wk High:16.15
Vol:1.67M
Avg Vol(3m):102.3M
1Y Chng:+175.13%
1M Chng:+52.49%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.50B